Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

NCT07384013 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Oncologic Diseases
Coagulation Defect
Pain Management

Interventions

DRUG: metamizole
DRUG: metamizole

Sponsor

Rambam Health Care Campus